Sort   by:  
 Page size 
UnknownTreatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Not available
S-EPMC4838083 | biostudies-literature
UnknownModification of Non-photochemical Quenching Pathways in the C<sub>4</sub> Model Plant <i>Setaria viridis</i> Revealed Shared and Unique Photoprotection Mechanisms as Compared to C<sub>3</sub> Plants.
Not available
S-EPMC11761403 | biostudies-literature
UnknownEnabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program.
Not available
S-EPMC11968805 | biostudies-literature
UnknownDigital health technologies in the accelerating medicines Partnership® Schizophrenia Program
Not available
S-EPMC12134270 | biostudies-literature
UnknownSample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.
Not available
S-EPMC11968923 | biostudies-literature
UnknownCognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.
Not available
S-EPMC11933323 | biostudies-literature
UnknownCollecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative.
Not available
S-EPMC12528486 | biostudies-literature
UnknownThe MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.
Not available
S-EPMC11965426 | biostudies-literature
UnknownDevelopment of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.
Not available
S-EPMC10899527 | biostudies-literature
UnknownThe electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures.
Not available
S-EPMC12144291 | biostudies-literature
Sort   by:  
 Page size